维奈克拉联合阿扎胞苷治疗老年急性髓系白血病的临床效果观察分析(Observation and analysis of the clinical efficacy of combination therapy with vinaclotide and azacitidine in the treatment of elderly acute myeloid leukemia)
临床用药研究(Clinical Pharmacotherapy Research) · 2025
DOI: 10.66106/lyyaa3.20250105 ↗Kurz gefasst
Fachartikel in der Zeitschrift 临床用药研究(Clinical Pharmacotherapy Research), 2025. Verfasst von 孙亚娟 Yajuan Sun. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Abstract:Objective: To investigate the clinical efficacy of combination therapy of vinaclotide and azacitidine in the treatment of elderly patients with acute myeloid leukemia (AML). Method: Sixty elderly AML patients were selected and randomly divided into an observation group and a control group,with 30 patients in each group. The observation group was treated with combination therapy of Vinaccra and Azacitidine,while the control group was treated with conventional chemotherapy regimen. Compare the clinical efficacy,bone marrow remission,blood indicators,and T lymphocyte subpopulation levels between two groups. The total effective rate of the observation group was 93.33%,which was higher than the control group's 70.00% (P
Zitieren
APA
Sun, 孙. Y. (2025). 维奈克拉联合阿扎胞苷治疗老年急性髓系白血病的临床效果观察分析(Observation and analysis of the clinical efficacy of combination therapy with vinaclotide and azacitidine in the treatment of elderly acute myeloid leukemia). 临床用药研究(Clinical Pharmacotherapy Research). https://doi.org/10.66106/lyyaa3.20250105
Vancouver
Sun 孙Y. 维奈克拉联合阿扎胞苷治疗老年急性髓系白血病的临床效果观察分析(Observation and analysis of the clinical efficacy of combination therapy with vinaclotide and azacitidine in the treatment of elderly acute myeloid leukemia). 临床用药研究(Clinical Pharmacotherapy Research). 2025. doi:10.66106/lyyaa3.20250105
BibTeX
@article{Sun2025,
author = {Sun, 孙亚娟 Yajuan},
title = {维奈克拉联合阿扎胞苷治疗老年急性髓系白血病的临床效果观察分析(Observation and analysis of the clinical efficacy of combination therapy with vinaclotide and azacitidine in the treatment of elderly acute myeloid leukemia)},
journal = {临床用药研究(Clinical Pharmacotherapy Research)},
year = {2025},
doi = {10.66106/lyyaa3.20250105}
}
EUVIMED